3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pheochromocytoma
2
Paraganglioma
2
Neuroendocrine Tumors
2
Meningioma
2
von Hippel-Lindau Disease
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Neuroendocrine Prostate Cancer
1
Kidney Neoplasms
1
Hypertension
1
Head and Neck Neoplasms
1
Ganglioneuroma
1
Ganglioneuroblastoma
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
Temozolomide
11
Radiotherapy
8
Radiation
5
Surgical Procedures, Operative
3
Biopsy
3
trametinib
2
dabrafenib
2
Spinal Puncture
2
Radiotherapy, Intensity-Modulated
2
Genetic Therapy
2
Craniotomy
2
Bevacizumab
2
vorasidenib
1
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
pembrolizumab
1
atezolizumab
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Standard of Care
1
Restraint, Physical
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
gallium Ga 68 dotatate
×
90 days
×
Clear all
No trials found.